selected publications
- Current landscape of CD3 bispecific antibodies in hematologic malignancies. Trends in cancer. 2024 Review GET IT
- Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene Rearrangements. Pathobiology : journal of immunopathology, molecular and cellular biology. 2023 Academic Article GET IT
-
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia.
NPJ precision oncology.
2021
Academic Article
GET IT
Times cited: 23 -
Chemical probes and methods for single-cell detection and quantification of epichaperomes in hematologic malignancies.
Methods in enzymology.
2020
Academic Article
GET IT
Times cited: 11 -
Clonal Hematopoiesis and Premalignant Diseases.
Cold Spring Harbor perspectives in medicine.
2020
Review
GET IT
Times cited: 12 -
HIV portends a poor prognosis in myelodysplastic syndromes.
Leukemia & lymphoma.
2019
Academic Article
GET IT
Times cited: 4 -
Risk factors and prognosis of ovarian vein thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
2017
Academic Article
GET IT
Times cited: 6 -
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.
The Journal of biological chemistry.
2016
Academic Article
GET IT
Times cited: 42 -
Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.
Oncotarget.
2016
Academic Article
GET IT
Times cited: 21 -
Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.
Immunotherapy.
2015
Review
GET IT
Times cited: 44